Attached files
file | filename |
---|---|
EX-99.1 - PRESS RELEASE - MMRGlobal, Inc. | exhibit99-1.pdf |
8-K - 8-K - MMRGlobal, Inc. | body8k.htm |
EXHIBIT 99.1
FOR IMMEDIATE RELEASE
Walgreens and MyMedicalRecords Reach Settlement Agreement
LOS ANGELES, CA and DEERFIELD, IL (March 6, 2014) -
MMRGlobal, Inc. (OTC: MMRF), through its wholly owned subsidiary MyMedicalRecords, Inc. (collectively, "MMR"), and Walgreen Co. (NYSE: WAG) (Nasdaq: WAG) ("Walgreens") announced today that they have entered into a Settlement and Licensing Agreement (the "Agreement") to resolve two patent infringement lawsuits brought by MMR. Pursuant to the terms of the Agreement, Walgreens purchased a Non-Exclusive License to the MMR family of patents. The settlement arises from litigation involving MMR's U.S. Patent No. 8,301,466 and U.S. Patent No. 8,498,883. MMR's patent portfolio also includes U.S. Patent Nos. 8,121,855; 8,117,045; 8,117,646; 8,301,466; 8,321,240; 8,352,287; 8,352,288; 8,498,883; 8,626,532 and 8,645,161 as well as numerous pending applications. Pursuant to the terms of the Agreement, Walgreens has also agreed to sell MMR's MyMedicalRecords Personal Health Record (the "MMR-PHR") on drugstore.com. The remaining terms of the Agreement are confidential.About MMRGlobal
MMRGlobal, Inc., through its wholly-owned subsidiary, MyMedicalRecords, Inc., (MMR) is a leading provider of secure and easy-to-use
online Personal Health Records ("PHRs") and electronic safe deposit box storage solutions incorporating its patented
About Walgreens
As the nation's largest drugstore chain with fiscal 2013 sales of $72 billion, Walgreens (www.walgreens.com) vision is to be the first
choice in health and daily living for everyone in America, and beyond. Each day, Walgreens provides more than 6 million customers the most
convenient, multichannel access to consumer goods and services and trusted, cost-effective pharmacy, health and wellness services and
advice in communities across America. Walgreens scope of pharmacy services includes retail, specialty, infusion, medical facility and mail
service, along with respiratory services. These services improve health outcomes and lower costs for payers including employers, managed
care organizations, health systems, pharmacy benefit managers and the public sector. The company operates 8,206 drugstores in all 50 states,
the District of Columbia, Puerto Rico and the U.S. Virgin Islands. Take Care Health Systems is a Walgreens subsidiary that is the largest and
most comprehensive manager of worksite health and wellness centers and in-store convenient care clinics, with more than 750 locations
throughout the country.
Forward-Looking Statements
All statements in this press release that are not strictly historical in nature, including, without limitation, intellectual property enforcement actions,
infringement claims or litigation, intellectual property licenses, and future performance, management's expectations, beliefs, intentions,
estimates or projections, constitute "forward-looking statements." Such forward-looking statements involve known and unknown risks,
uncertainties and other factors that may cause MMR's actual results to be materially different from historical results or from any results
expressed or implied by such forward-looking statements. Some can be identified by the use of words (and their derivations) such as "need,"
"possibility," "potential," "intend," "offer," "development," "if," "negotiate," "when," "begun," "believe," "achieve," "will," "estimate," "expect,"
"maintain," "plan," and "continue," or the negative of these words. Actual outcomes and results of operations and the timing of selected events
may differ materially from the results predicted, and any reported results should not be considered as an indication of future performance. Such
statements are necessarily based on assumptions and estimates and are subject to various risks and uncertainties, including those relating to
the possible invalidity of the underlying assumptions and estimates and possible changes or developments in economic, business, industry,
market, legal and regulatory circumstances and conditions and actions taken or omitted to be taken by third parties, including customers,
suppliers, business partners, potential licensees, competitors and legislative, judicial and other governmental authorities and officials. Factors
that could cause or contribute to such differences include, but are not limited to: unexpected outcomes with respect to intellectual property
enforcement actions, claims of intellectual property infringement and general intellectual property litigation; our ability to maintain, develop,
monetize and protect our patent portfolio for both MMR's health IT and biotechnology intellectual property assets in the U.S. and internationally;
the timing of milestone payments in connection with licensing our intellectual property; our ability to establish and maintain strategic
relationships; changes in our relationships with our licensees; the risk MMR's products are not adopted or viewed favorably by the healthcare
community and consumer retail market; business prospects, results of operations or financial condition; risks related to the current uncertainty
and instability in financial and lending markets, including global economic uncertainties; the timing and volume of sales and installations; the
length of sales cycles and the installation process; the market's acceptance of new product and service introductions; competitive product
offerings and promotions; changes in government laws and regulations including the 2009 HITECH Act and changes in Meaningful Use and the
2010 Affordable Care Act; future changes in tax legislation and initiatives in the healthcare industry; undetected errors in our products; the
possibility of interruption at our data centers; risks related to third party vendors; risks related to obtaining and integrating third-party licensed
technology; risks related to a security breach by third parties; risks associated with recruitment and retention of key personnel; other litigation
matters; uncertainties associated with doing business internationally across borders and territories; and additional risks discussed in MMR's
filings with the Securities and Exchange Commission. MMR is providing this information as of the date of this release and, except as required by
applicable law, does not undertake any obligation to update any forward-looking statements contained in this release as a result of new
information, future events or otherwise.
###
CONTACT:
MMRGlobal:
Bobbie Volman
(310) 476-7002, Ext. 7015